228 related articles for article (PubMed ID: 32114828)
1. Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
Augusto JB; Nordin S; Vijapurapu R; Baig S; Bulluck H; Castelletti S; Alfarih M; Knott K; Captur G; Kotecha T; Ramaswami U; Tchan M; Geberhiwot T; Fontana M; Steeds RP; Hughes D; Kozor R; Moon JC
Circ Cardiovasc Imaging; 2020 Mar; 13(3):e010171. PubMed ID: 32114828
[TBL] [Abstract][Full Text] [Related]
2. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
[TBL] [Abstract][Full Text] [Related]
3. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
Augusto JB; Johner N; Shah D; Nordin S; Knott KD; Rosmini S; Lau C; Alfarih M; Hughes R; Seraphim A; Vijapurapu R; Bhuva A; Lin L; Ojrzyńska N; Geberhiwot T; Captur G; Ramaswami U; Steeds RP; Kozor R; Hughes D; Moon JC; Namdar M
Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):790-799. PubMed ID: 32514567
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
Nordin S; Kozor R; Vijapurapu R; Augusto JB; Knott KD; Captur G; Treibel TA; Ramaswami U; Tchan M; Geberhiwot T; Steeds RP; Hughes DA; Moon JC
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009430. PubMed ID: 31826677
[TBL] [Abstract][Full Text] [Related]
5. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
Vijapurapu R; Nordin S; Baig S; Liu B; Rosmini S; Augusto J; Tchan M; Hughes DA; Geberhiwot T; Moon JC; Steeds RP; Kozor R
Heart; 2019 Mar; 105(6):470-476. PubMed ID: 30282640
[TBL] [Abstract][Full Text] [Related]
6. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Clinical Evolution in Prehypertrophic Fabry Disease.
Camporeale A; Pieroni M; Pieruzzi F; Lusardi P; Pica S; Spada M; Mignani R; Burlina A; Bandera F; Guazzi M; Graziani F; Crea F; Greiser A; Boveri S; Ambrogi F; Lombardi M
Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008424. PubMed ID: 30943767
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.
Pica S; Sado DM; Maestrini V; Fontana M; White SK; Treibel T; Captur G; Anderson S; Piechnik SK; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Kellman P; Elliott PM; Herrey AS; Moon JC
J Cardiovasc Magn Reson; 2014 Dec; 16(1):99. PubMed ID: 25475749
[TBL] [Abstract][Full Text] [Related]
9. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
Weidemann F; Beer M; Kralewski M; Siwy J; Kampmann C
Mol Genet Metab; 2019 Feb; 126(2):169-182. PubMed ID: 30594474
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Phenotype of Prehypertrophic Fabry Disease.
Nordin S; Kozor R; Baig S; Abdel-Gadir A; Medina-Menacho K; Rosmini S; Captur G; Tchan M; Geberhiwot T; Murphy E; Lachmann R; Ramaswami U; Edwards NC; Hughes D; Steeds RP; Moon JC
Circ Cardiovasc Imaging; 2018 Jun; 11(6):e007168. PubMed ID: 29853467
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping.
Réant P; Testet E; Reynaud A; Bourque C; Michaud M; Rooryck C; Goizet C; Lacombe D; de-Précigout V; Peyrou J; Cochet H; Lafitte S
Int J Cardiovasc Imaging; 2020 Jul; 36(7):1333-1342. PubMed ID: 32385539
[TBL] [Abstract][Full Text] [Related]
12. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
[TBL] [Abstract][Full Text] [Related]
13. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
Chen X; Zhao S; Zhao T; Lu M; Yin G; Jiang S; Prasad S
Eur J Radiol; 2014 Feb; 83(2):297-302. PubMed ID: 24332848
[TBL] [Abstract][Full Text] [Related]
14. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
Sado DM; White SK; Piechnik SK; Banypersad SM; Treibel T; Captur G; Fontana M; Maestrini V; Flett AS; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Neubauer S; Elliott PM; Moon JC
Circ Cardiovasc Imaging; 2013 May; 6(3):392-8. PubMed ID: 23564562
[TBL] [Abstract][Full Text] [Related]
15. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.
Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Choudhury RP; Friedrich MG; Robson MD; Neubauer S
J Cardiovasc Magn Reson; 2012 Jun; 14(1):42. PubMed ID: 22720998
[TBL] [Abstract][Full Text] [Related]
16. Acute impact of an endurance race on cardiac function and biomarkers of myocardial injury in triathletes with and without myocardial fibrosis.
Tahir E; Scherz B; Starekova J; Muellerleile K; Fischer R; Schoennagel B; Warncke M; Stehning C; Cavus E; Bohnen S; Radunski UK; Blankenberg S; Simon P; Pressler A; Adam G; Patten M; Lund GK
Eur J Prev Cardiol; 2020 Jan; 27(1):94-104. PubMed ID: 31242053
[TBL] [Abstract][Full Text] [Related]
17. Myocardial lipid content in Fabry disease: a combined
Petritsch B; Köstler H; Weng AM; Horn M; Gassenmaier T; Kunz AS; Weidemann F; Wanner C; Bley TA; Beer M
BMC Cardiovasc Disord; 2016 Oct; 16(1):205. PubMed ID: 27793097
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping.
Deborde E; Dubourg B; Bejar S; Brehin AC; Normant S; Michelin P; Dacher JN
Diagn Interv Imaging; 2020 Feb; 101(2):59-67. PubMed ID: 31519470
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Myocardial Perfusion in Fabry Disease.
Knott KD; Augusto JB; Nordin S; Kozor R; Camaioni C; Xue H; Hughes RK; Manisty C; Brown LAE; Kellman P; Ramaswami U; Hughes D; Plein S; Moon JC
Circ Cardiovasc Imaging; 2019 Jul; 12(7):e008872. PubMed ID: 31269811
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.
Deva DP; Hanneman K; Li Q; Ng MY; Wasim S; Morel C; Iwanochko RM; Thavendiranathan P; Crean AM
J Cardiovasc Magn Reson; 2016 Mar; 18():14. PubMed ID: 27036375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
